Page last updated: 2024-11-02

phenylmethylsulfonyl fluoride and Brain Neoplasms

phenylmethylsulfonyl fluoride has been researched along with Brain Neoplasms in 1 studies

Phenylmethylsulfonyl Fluoride: An enzyme inhibitor that inactivates IRC-50 arvin, subtilisin, and the fatty acid synthetase complex.
phenylmethanesulfonyl fluoride : An acyl fluoride with phenylmethanesulfonyl as the acyl group.

Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jacobsson, SO1
Fowler, CJ1

Other Studies

1 other study available for phenylmethylsulfonyl fluoride and Brain Neoplasms

ArticleYear
Characterization of palmitoylethanolamide transport in mouse Neuro-2a neuroblastoma and rat RBL-2H3 basophilic leukaemia cells: comparison with anandamide.
    British journal of pharmacology, 2001, Volume: 132, Issue:8

    Topics: Amides; Animals; Arachidonic Acids; Brain Neoplasms; Cannabinoids; Cell Survival; Endocannabinoids;

2001